https://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-global-pharmaceutical-partner-seeks-novel-therapeutics-and-platform-technologies-through-strategic-collaborations/Next Phase Newsletteren2026-07-21T17:27:14+00:00Hot Investor Mandate: Global Pharmaceutical Partner Seeks Novel Therapeutics and Platform Technologies Through Strategic Collaborationstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-vc-firm-invests-exclusively-in-differentiated-therapeutics-across-all-development-stages-focusing-on-usa-based-companies/Next Phase Newsletteren2026-07-21T17:26:56+00:00Hot Investor Mandate: VC Firm Invests Exclusively in Differentiated Therapeutics Across All Development Stages, Focusing on USA-Based Companiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-cross-border-vc-firm-backs-life-science-companies-in-high-unmet-need-areas-including-cns-immuno-oncology-and-more/Next Phase Newsletteren2026-07-21T17:26:41+00:00Hot Investor Mandate: Cross-Border VC Firm Backs Life Science Companies in High Unmet Need Areas Including CNS, Immuno-Oncology, and Moretechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-early-stage-vc-firm-invests-up-to-20m-in-novel-first-in-class-therapeutics-companies-with-us-and-europe-focus/Next Phase Newsletteren2026-07-21T17:26:25+00:00Hot Investor Mandate: Early-Stage VC Firm Invests Up to $20M in Novel, First-In-Class Therapeutics Companies With US and Europe Focus technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence